Matinas BioPharma
MTNB
MTNB
71 hedge funds and large institutions have $57.1M invested in Matinas BioPharma in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Holders
71
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.66M | |
| 2 | +$1.01M | |
| 3 | +$894K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$854K |
| 5 |
Millennium Management
New York
|
+$531K |
Top Sellers
| 1 | -$6.57M | |
| 2 | -$1.86M | |
| 3 | -$566K | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$548K |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$335K |